Metropolitan Life Insurance Company (MetLife)’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-382
| Closed | -$3.08K | – | 1033 |
|
|
2024
Q1 | $3.08K | Sell |
382
-914
| -71% | -$6.47K | ﹤0.01% | 2274 |
|
|
2023
Q4 | $7.12K | Hold |
1,296
| – | – | ﹤0.01% | 2261 |
|
|
2023
Q3 | $6.76K | Hold |
1,296
| – | – | ﹤0.01% | 2365 |
|
|
2023
Q2 | $15K | Hold |
1,296
| – | – | ﹤0.01% | 2085 |
|
|
2023
Q1 | $16.2K | Hold |
1,296
| – | – | ﹤0.01% | 1986 |
|
|
2022
Q4 | $25.5K | Hold |
1,296
| – | – | ﹤0.01% | 1873 |
|
|
2022
Q3 | $31.5K | Hold |
1,296
| – | – | ﹤0.01% | 1772 |
|
|
2022
Q2 | $31.3K | Hold |
1,296
| – | – | ﹤0.01% | 1791 |
|
|
2022
Q1 | $42K | Sell |
1,296
-4,479
| -78% | -$141K | ﹤0.01% | 1693 |
|
|
2021
Q4 | $196K | Hold |
5,775
| – | – | ﹤0.01% | 2039 |
|
|
2021
Q3 | $249K | Hold |
5,775
| – | – | ﹤0.01% | 1913 |
|
|
2021
Q2 | $376K | Buy |
5,775
+312
| +6% | +$19.7K | 0.01% | 1706 |
|
|
2021
Q1 | $287K | Sell |
5,463
-335
| -6% | -$16.7K | ﹤0.01% | 1771 |
|
|
2020
Q4 | $259K | Hold |
5,798
| – | – | ﹤0.01% | 1762 |
|
|
2020
Q3 | $168K | Hold |
5,798
| – | – | ﹤0.01% | 1890 |
|
|
2020
Q2 | $206K | Hold |
5,798
| – | – | ﹤0.01% | 1776 |
|
|
2020
Q1 | $300K | Hold |
5,798
| – | – | 0.01% | 1355 |
|
|
2019
Q4 | $396K | Sell |
5,798
-784
| -12% | -$49.2K | 0.01% | 1472 |
|
|
2019
Q3 | $315K | Sell |
6,582
-3,878
| -37% | -$202K | 0.01% | 1582 |
|
|
2019
Q2 | $698K | Buy |
10,460
+25
| +0.2% | +$1.9K | 0.01% | 1100 |
|
|
2019
Q1 | $995K | Buy |
10,435
+61
| +0.6% | +$7.61K | 0.02% | 879 |
|
|
2018
Q4 | $1.29M | Buy |
10,374
+4,688
| +82% | +$772K | 0.03% | 660 |
|
|
2018
Q3 | $1.39M | Hold |
5,686
| – | – | 0.02% | 737 |
|
|
2018
Q2 | $1.06M | Buy |
5,686
+52
| +0.9% | +$8.65K | 0.02% | 892 |
|
|
2018
Q1 | $692K | Buy |
5,634
+109
| +2% | +$13.3K | 0.01% | 1077 |
|
|
2017
Q4 | $658K | Sell |
5,525
-6,079
| -52% | -$669K | 0.01% | 1094 |
|
|
2017
Q3 | $1.1M | Hold |
11,604
| – | – | 0.01% | 1193 |
|
|
2017
Q2 | $1.11M | Buy |
11,604
+883
| +8% | +$75.5K | 0.01% | 1185 |
|
|
2017
Q1 | $832K | Sell |
10,721
-667
| -6% | -$46.2K | 0.01% | 1327 |
|
|
2016
Q4 | $765K | Hold |
11,388
| – | – | 0.01% | 1453 |
|
|
2016
Q3 | $682K | Hold |
11,388
| – | – | 0.01% | 1507 |
|
|
2016
Q2 | $571K | Hold |
11,388
| – | – | ﹤0.01% | 1604 |
|
|
2016
Q1 | $512K | Hold |
11,388
| – | – | ﹤0.01% | 1565 |
|
|
2015
Q4 | $457K | Hold |
11,388
| – | – | ﹤0.01% | 1676 |
|
|
2015
Q3 | $553K | Sell |
11,388
-83
| -0.7% | -$3.94K | ﹤0.01% | 1571 |
|
|
2015
Q2 | $512K | Buy |
+11,471
| New | +$440K | ﹤0.01% | 1727 |
|
Other funds holding INGN
DSCM
CCM
BCM
FAM
BCM
Metropolitan Life Insurance Company (MetLife)'s INGN Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Inogen (INGN) in Q2 2024, closing a stake of 382 shares — an estimated $3.08K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in INGN in Q2 2015 and held it in 36 quarters. The position peaked at $1.39M in Q3 2018. 130 funds tracked by Wall St. Rank hold INGN as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Inogen position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 382 Inogen shares in Q2 2024, an estimated $3.08K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Inogen in Q2 2015 and held it in 36 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Inogen position peaked at $1.39M in Q3 2018.
- 130 funds tracked by Wall St. Rank held Inogen as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.